BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 18064580)

  • 1. Toward understanding nonparticipation in sigmoidoscopy screening for colorectal cancer.
    Blom J; Yin L; Lidén A; Dolk A; Jeppsson B; Påhlman L; Holmberg L; Nyrén O
    Int J Cancer; 2008 Apr; 122(7):1618-23. PubMed ID: 18064580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 9-year follow-up study of participants and nonparticipants in sigmoidoscopy screening: importance of self-selection.
    Blom J; Yin L; Lidén A; Dolk A; Jeppsson B; Påhlman L; Holmberg L; Nyrén O
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1163-8. PubMed ID: 18483338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in colorectal cancer testing among Medicare subpopulations.
    Fenton JJ; Cai Y; Green P; Beckett LA; Franks P; Baldwin LM
    Am J Prev Med; 2008 Sep; 35(3):194-202. PubMed ID: 18619761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
    Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
    J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of nonparticipants in a randomised colorectal cancer screening trial comparing sigmoidoscopy and faecal immunochemical testing.
    Botteri E; Hoff G; Randel KR; Holme Ø; de Lange T; Bernklev T; Aas E; Berthelsen M; Natvig E; Kirkøen B; Knudsen MD; Kvaerner AS; Schult AL; Ursin G; Jørgensen A; Berstad P
    Int J Cancer; 2022 Aug; 151(3):361-371. PubMed ID: 35411554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reasons for non-participation in population-based abdominal aortic aneurysm screening.
    Linne A; Leander K; Lindström D; Törnberg S; Hultgren R
    Br J Surg; 2014 Apr; 101(5):481-7. PubMed ID: 24615380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation in a sigmoidoscopic colorectal cancer screening program: a pilot study.
    Kremers SP; Mesters I; Pladdet IE; van den Borne B; Stockbrügger RW
    Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1127-30. PubMed ID: 11045799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of marital status and colorectal cancer screening participation in the USA.
    El-Haddad B; Dong F; Kallail KJ; Hines RB; Ablah E
    Colorectal Dis; 2015 May; 17(5):O108-14. PubMed ID: 25704636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing different strategies for colorectal cancer screening in Italy: predictors of patients' participation.
    Senore C; Armaroli P; Silvani M; Andreoni B; Bisanti L; Marai L; Castiglione G; Grazzini G; Taddei S; Gasperoni S; Giuliani O; Malfitana G; Marutti A; Genta G; Segnan N
    Am J Gastroenterol; 2010 Jan; 105(1):188-98. PubMed ID: 19826409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of advanced proximal neoplasms according to distal colorectal findings: comparison of sigmoidoscopy-based strategies.
    Castells A; Bessa X; Quintero E; Bujanda L; Cubiella J; Salas D; Lanas A; Carballo F; Morillas JD; Hernández C; Jover R; Montalvo I; Arenas J; Cosme A; Hernández V; Iglesias B; Castro I; Cid L; Sala T; Ponce M; Andrés M; Teruel G; Peris A; Roncales MP; González-Rubio F; Seoane-Urgorri A; Grau J; Serradesanferm A; Pellisé M; Ono A; Cruzado J; Pérez-Riquelme F; Alonso-Abreu I; Carrillo-Palau M; de la Vega-Prieto M; Iglesias R; Amador J; Blanco JM; Sastre R; Ferrándiz J; González-Hernández MJ; Andreu M;
    J Natl Cancer Inst; 2013 Jun; 105(12):878-86. PubMed ID: 23708054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Female gender and other factors predictive of a limited screening flexible sigmoidoscopy examination for colorectal cancer.
    Eloubeidi MA; Wallace MB; Desmond R; Farraye FA
    Am J Gastroenterol; 2003 Jul; 98(7):1634-9. PubMed ID: 12873591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting compliance with colorectal cancer screening in France: differences between intention to participate and actual participation.
    Herbert C; Launoy G; Gignoux M
    Eur J Cancer Prev; 1997 Feb; 6(1):44-52. PubMed ID: 9161812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding non-compliance to colorectal cancer screening: a case control study, nested in a randomised trial [ISRCTN83029072].
    Giorgi Rossi P; Federici A; Bartolozzi F; Farchi S; Borgia P; Guasticchi G
    BMC Public Health; 2005 Dec; 5():139. PubMed ID: 16372903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding Barriers to Colorectal Cancer Screening in Kentucky.
    Knight JR; Kanotra S; Siameh S; Jones J; Thompson B; Thomas-Cox S
    Prev Chronic Dis; 2015 Jun; 12():E95. PubMed ID: 26086608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marriage and cancer prevention: does marital status and inviting both spouses together influence colorectal cancer screening participation?
    van Jaarsveld CH; Miles A; Edwards R; Wardle J
    J Med Screen; 2006; 13(4):172-6. PubMed ID: 17217605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the type of test used for mass colorectal cancer screening a determinant of compliance? A cluster-randomized controlled trial comparing fecal occult blood testing with flexible sigmoidoscopy.
    Federici A; Marinacci C; Mangia M; Borgia P; Giorgi Rossi P; Guasticchi G
    Cancer Detect Prev; 2006; 30(4):347-53. PubMed ID: 16965874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body mass index and up-to-date colorectal cancer screening among Marylanders aged 50 years and older.
    Menis M; Kozlovsky B; Langenberg P; Zhan M; Dwyer DM; Israel E; Groves C; Hopkins A; Steinberger EK
    Prev Chronic Dis; 2006 Jul; 3(3):A88. PubMed ID: 16776889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial.
    Weissfeld JL; Schoen RE; Pinsky PF; Bresalier RS; Church T; Yurgalevitch S; Austin JH; Prorok PC; Gohagan JK;
    J Natl Cancer Inst; 2005 Jul; 97(13):989-97. PubMed ID: 15998952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial).
    Denis B; Gendre I; Aman F; Ribstein F; Maurin P; Perrin P
    Eur J Cancer; 2009 Dec; 45(18):3282-90. PubMed ID: 19665368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.